Skip to main content

Pacira Pharm Inc(PCRX-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Pacira Pharm Inc

5401 WEST KENNEDY BOULEVARD SUITE 890
TAMPA FL 33609 USA
P: 813-553-6680
http://www.pacira.com

Profile

Pacira BioSciences, Inc. is a specialty pharmaceutical company focused on the development, commercialization and manufacture of proprietary pharmaceutical products primarily for use in hospitals and ambulatory surgery centers. These products are developed using the company's proprietary DepoFoam drug delivery technology. Pacira changed its name to Pacira BioSciences following the acquisition of MyoScience. Exparel, the company's flagship product, is a liposome injection of bupivacaine, which is indicated for single-dose administration into the surgical site to produce postsurgical analgesia. The company signed a licensing agreement with Aratana for the development and commercialization of Exparel for animal health indications.

Key Executives

NameTitle
Charles A. ReinhartCFO
Kristen Marie WilliamsChief Administrative Officer/Secretary
Frank D. LeeCEO/Director
Jonathan SloninChief Medical Officer
Daryl GauglerCOO

More from The Globe